Hacker News
- Tirzepatide Once Weekly for the Treatment of Obesity https://www.nejm.org/doi/full/10.1056/NEJMoa2206038 2 comments
- A weekly dose of a diabetes drug appears to lead to significant weight loss in people with obesity. Used alongside interventions like exercise participants in a 72-week trial lost as much as 20% of their body weight. https://www.nejm.org/doi/full/10.1056/NEJMoa2206038 111 comments science
Linking pages
- Diabetes drug could be a game changer for obesity, new study shows https://www.usatoday.com/story/news/health/2022/06/04/diabetes-drug-could-game-changer-obesity-new-study-shows/7490446001/ 1908 comments
- Should We End Obesity? | TIME https://time.com/6330809/ozempic-wegovy-mounjaro-healthy/ 462 comments
- Diabetes drug leads to notable weight loss in people with obesity – study | Medical research | The Guardian https://www.theguardian.com/science/2022/jun/05/diabetes-drug-tirzepatide-leads-to-notable-weight-loss-in-people-with-obesity-study 332 comments
- New Weight Loss Drugs Are on the Way That Could Upstage Wegovy and Ozempic https://www.verywellhealth.com/innovations-in-weight-loss-drugs-oral-and-injectable-7510595 313 comments
- Mounjaro, the ‘next Ozempic’ became a social media sensation. Then everything changed | The Independent https://www.independent.co.uk/news/world/americas/ozempic-mounjaro-side-effects-diabetes-weight-loss-b2288015.html 289 comments
- Why You Will Stop Losing Weight on Ozempic - The Atlantic https://www.theatlantic.com/health/archive/2024/01/why-you-will-stop-losing-weight-ozempic/677148/ 95 comments
- You Could Take Ozempic and Not Lose Any Weight - The Atlantic https://theatln.tc/9TLocF99 94 comments
- Mounjaro, the ‘next Ozempic’ became a social media sensation. Then everything changed | The Independent https://www.independent.co.uk/news/world/americas/mounjaro-weight-loss-ozempic-face-b2289417.html 76 comments
- A Drug Half as Good as Ozempic for One-30th the Price - The Atlantic https://www.theatlantic.com/health/archive/2024/03/topiramate-glp1-ozempic-alternatives/677884/ 41 comments
- Diabetes Drug Leads to Weight Loss for People With Obesity https://www.today.com/health/diet-fitness/drug-weight-loss-obesity-rcna32297 30 comments
- Ozempic Is About to Be Old News - The Atlantic https://www.theatlantic.com/health/archive/2023/04/ozempic-wegovy-mounjaro-weight-loss-drug-development-access/673627/ 16 comments
- The New Obesity Breakthrough Drugs - by Eric Topol https://erictopol.substack.com/p/the-new-obesity-breakthrough-drugs 5 comments
- 2022 FDA approvals https://www.nature.com/articles/d41573-023-00001-3 3 comments
- Weight-Loss Surgery Still Beats Ozempic - The Atlantic https://www.theatlantic.com/health/archive/2023/04/weight-loss-surgeons-arent-worried-about-ozempic/673853/ 3 comments
- Overweight people lost 35 to 52 pounds on newly approved diabetes drug, study says | CNN https://www.cnn.com/2022/06/06/health/weight-loss-drug-diabetes-wellness/index.html 1 comment
- Tirzepatide shown to be effective weight loss drug in phase III clinical trial - https://medlifestyle.news/tirzepatide-shown-to-be-effective-weight-loss-drug-in-phase-iii-clinical-trial/ 0 comments
- New diabetes drug helped obese people without the disease lose incredible amounts of weight | Boing Boing https://boingboing.net/2022/06/07/new-diabetes-drug-helped-obese-people-without-the-disease-lose-incredible-amounts-of-weight.html 0 comments
- The Future of Weight Loss Looks a Lot Like Its Past | WIRED https://www.wired.com/story/fda-weight-loss-drugs/ 0 comments
- F.D.A. Approves New Obesity Drug Tirzepatide That Will Compete With Wegovy - The New York Times https://www.nytimes.com/2023/11/08/health/fda-tirzepatide-obesity-zepbound-wegovy.html 0 comments
- What To Know About Retatrutide: Unapproved Drug Boasts Greater Weight Loss Than Ozempic, Mounjaro, Wegovy https://www.forbes.com/sites/ariannajohnson/2023/06/27/what-to-know-about-retatrutide-unapproved-drug-boasts-greater-weight-loss-than-ozempic-mounjaro-wegovy/ 0 comments
Related searches:
Search whole site: site:doi.org
Search title: Tirzepatide Once Weekly for the Treatment of Obesity | NEJM
See how to search.